Author:
Bruno René,Iliadis Marie-Camille,Lacarelle Bruno,Cosson Val'erie,Mandema Jaap W.,Le Roux Yvonne,Montay Guy,Durand Alain,Ballereau Michel,Alasia Marc,Albanese Jacques,Francois Georges,Iliadis Athanassios,Frydman Armand
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference34 articles.
1. L. B. Sheiner, B. Rosenberg, and V. V. Marathe. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.J. Pharmacokin. Biopharm. 5:445–479 (1977).
2. L. B. Sheiner and T. H. Grasela. An Introduction to mixed effect modeling: concepts, definitions and justification.J. Pharmacokin. Biopharm. 19(Suppl.):11–24 (1991).
3. L. B. Sheiner. Population approach in drug development: rationale and basic concepts. In M. Rowland and L. Aarons (eds.),New Strategies in Drug Development and Clinical Evaluation: The Population Approach, Commission of European Communities, Brussels, 1992, pp. 13–29.
4. R. Temple. The clinical investigation of drugs for use by the elderly: Food and drug guidelines.Clin. Pharmacol. Ther. 42:681–685 (1987).
5. C. C. Peck. Population approach in pharmacokinetics and pharmacodynamics: FDA view. In M. Rowland and L. Aarons (eds.),New Strategies in Drug Development and Clinical Evaluation: The Population Approach, Commission of European Communities, Brussels, 1992, pp. 157–168.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献